Sign inJoin waitlistJoin the waitlist

Abhishek Maiti

Assistant Professor · University of Texas M D Anderson Cancer Center

Credentials: · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
2017–2020
Internal Medicine
University of Texas Health Science Center at Houston
2014–2017
Nilratan Sircar Medical College and Hospital
2010–2011
Doctor of Medicine
2007–2011

Research

Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
Journal of Clinical Oncology · 2021 · 294 citations
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
The Lancet Haematology · 2020 · 280 citations
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax
Cancer · 2021 · 155 citations

Hagop Kantarjian
66 papers
Nicholas Short
66 papers · 5 as a fellow
Tapan Kadia
64 papers
Courtney DiNardo
62 papers
Naval Daver
62 papers
GB
Gautam Borthakur
55 papers
Elias Jabbour
52 papers
Marina Konopleva
51 papers
Guillermo Garcia-Manero
47 papers
Musa Yilmaz
42 papers
Ghayas Issa
41 papers
KS
Koji Sasaki
35 papers

Clinical trials

Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
Principal investigator · Not yet recruiting · Phase 1
M.D. Anderson Cancer Center
2027–2031
Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia
Principal investigator · Not yet recruiting · Phase 1
M.D. Anderson Cancer Center
2026–2031
Phase I Study of Q702 With Azacitidine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Active not recruiting · Phase 1
M.D. Anderson Cancer Center
2025–2028
Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
Principal investigator · Withdrawn · Phase 1
M.D. Anderson Cancer Center
2024